Related Experiment Video
Updated: Jan 20, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
External beam radiation for HCC: Ready for incorporation into guidelines?
Michael Buckstein1, Laura A Dawson2
1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
External beam radiation therapy shows excellent results for managing hepatocellular carcinoma across all stages. Incorporating this effective, low-cost treatment into guidelines can significantly improve patient outcomes globally.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Hepatocellular carcinoma (HCC) management is evolving.
- External beam radiation therapy (EBRT) is an emerging treatment modality for HCC.
Purpose of the Study:
- To review the evidence supporting EBRT in HCC management.
- To advocate for the inclusion of EBRT in clinical guidelines for HCC.
Main Methods:
- Systematic review of current evidence.
- Analysis of randomized trials across all HCC stages.
Main Results:
- EBRT demonstrates excellent efficacy in early, intermediate, advanced, and palliative HCC stages.
- Growing body of evidence supports its use.
Conclusions:
- EBRT is a valuable tool for HCC management.
- Inclusion in guidelines can improve patient outcomes due to its effectiveness, low cost, and global availability.
Related Concept Videos
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
09:53Molecular Beam Mass Spectrometry With Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Ready Mixed Concrete
08:17Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Biological Effects of Radiation

